Clinical Trial Patient Recruitment Services Market Size | 2035

1. Clinical Trial Patient Recruitment Services Market Size | 2035 The patient recruitment and retention services market is estimated to be worth USD 26 billion in 2035, predicts Roots Analysis. Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expedite the drug development timelines. The report features an extensive study of companies engaged in offering patient recruitment and retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes: ▪ A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials. A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials. A detailed assessment of the overall landscape of companies offering patient recruitment and retention services. ▪ ▪

2. ▪ A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large). Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific. An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022. A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence. A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years. A case study on the regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework. A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases. A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players. A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Patient Recruitment Step ▪ ▪ Pre-screening Screening ▪ Trial Phase ▪ ▪ ▪ ▪ Phase I Phase II Phase III Phase IV ▪ Therapeutic Area ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Cardiovascular Disorders Oncological Disorders Infectious Diseases CNS Disorders Respiratory Disorders Hematological Disorders Dermatological Disorders Ophthalmic Disorders Others ▪ Key Geographical Regions ▪ ▪ ▪ ▪ ▪ North America Europe Asia Pacific Latin America Middle East and North Africa

3. ▪ Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies: ▪ ▪ Susan Fitzpatrick-Napier (Founder and Director, TrialWire) Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials) Simon Klaasen (Co-founder and Managing Director, Link2Trials) Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness) Ken Shore (Chief Commercial Officer, Continuum Clinical) Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed) Paul Ivsin (Ex-Managing Director, Seeker Health) Kasturi Lakhe (Inside Sales Specialist, EVERSANA) ▪ ▪ ▪ ▪ ▪ ▪ Key companies covered in the report ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ BBK Worldwide Continuum Clinical IQVIA United BioSource (UBC) WCG ThreeWire Clariness Fidelis Research Ignite Data Innovative Trials Orphan Reach 3H Medi Solution Buzzreach Current Medical Information Center (CMIC) nRollmed Trialfacts Key Market Insights ▪ Currently, over 150 companies claim to offer patient recruitment and retention services to the pharmaceutical and medical device industries, using a variety of conventional and innovative outreach methods. The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions. ▪ ▪ Most of the companies offer pre-screening of the potential study candidates and protocol development services to their clients; providing study-branded amenities is the most popular patient retention strategy . ▪ In order to gain a competitive edge and cater to the requirements of the clients, firms are actively improving their capabilities and enhancing their respective service portfolios. ▪ The increasing preference of trial sponsors to outsource patient recruitment-related activities is evident from the increase in partnership activity; in fact, more than 35% of the deals were forged in the last three years.

4. ▪ Rising clinical research activity, specifically focused on rare and complex disease indications, is anticipated to create lucrative business opportunities for patient recruitment and retention service providers. ▪ The demand for participants in clinical research is rising, and gradually becoming more complex owing to stringent regulatory guidelines; by 2035, around 21 million patients are expected to be enrolled in clinical trials. ▪ The market is expected to grow at a steady rate till 2035; the projected opportunity is likely to be well distributed across different steps in the patient recruitment process, trial phase and therapeutic area. ▪ In terms of annual service revenues, North America is likely to capture majority share in the patient recruitment market; however, Asia Pacific is anticipated to grow at a higher rate compared to other geographies. Key Inclusions ▪ A general overview of the clinical trials, featuring information on the different phases of clinical trials and their importance. The chapter also lays emphasis on the patient recruitment process, its associated challenges and the different strategies used to enhance patient enrolment in clinical research studies. It also presents information on the affiliated ethical considerations and outsourcing activity in this domain. Further, it features an elaborate discussion on the various patient recruitment associated services offered by contract service providers as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.

5. ▪ A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials. Further, the chapter highlights the various advantages and limitations of these outreach methods. ▪ A detailed competitiveness analysis of patient recruitment and retention service providers, taking into consideration supplier strength (based on their experience in this field) and service strength (based on number of patient outreach methods, number of patient recruitment associated service(s) offered, number of patient retention method(s) used, geographical reach and therapeutic expertise). ▪ Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering patient recruitment and retention services, across North America, Europe, and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, along with details related to its patient recruitment and retention service portfolio, recent developments and an informed future outlook. ▪ A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence, to overcome the challenges associated with patient enrolment and retention. ▪ A detailed discussion on the key growth opportunities (such as rise in the number of clinical trials, development of personalized medicines / orphan drugs, growing opportunities in emerging markets, increasing preference for one-stop solutions, stringent regulations related to patient enrollment and technological advancements in clinical trial conduct) in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years. ▪ A case study on regulatory landscape of patient recruitment, highlighting the regulatory process involved in patient enrollment, along with the information on regulatory guidelines, regulatory framework for patient recruitment, ethics committees in different countries and documents reviewed by the ethics committees. ▪ A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases, highlighting the key challenges in patient enrollment, specialized patient outreach methods being used to recruit and the key players engaged in this field. For more information, please click on the following link: https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-mark et/245.html About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com